ERBB2 and breast cancer: When over expressed in breast cancer cell lines, miR-125b suppresses HER2 and HER3 mRNA and protein levels leading to a reduction in anchorage-dependent growth, cell motility and invasiveness (O’Day and Lal, 2010).